HKMA and SFC propose to adopt a 'big bang' approach to implementation, rolling out the UTI, UPI, CDE and ISO 20022 requirements on 29 September 2025.
March 25, 2024New FAQs are provided to support implementation of the new OTC derivatives reporting regime, which comes into force in October.
February 16, 2024The more challenging aspects of implementation involve jurisdiction-specific data fields, the UTI waterfall, UTI generation, and ISO 20022.
January 10, 2024DTCC's Chris Childs and Priya Kundamal say there is no replacement for early testing to ensure data and reporting systems are fit for purpose.
January 4, 2024The final guidelines remove the “UPI” and “Delta” requirements from the 1 April 2024 go-live date.
November 22, 2023DTCC's Chris Childs discusses the top considerations for reporting rule rewrites for OTC derivatives in Asia Pacific.
September 8, 2023The FSA is making changes to its guidelines to remove the "UPI" and "Delta" requirements from the 1 April 2024 go-live date.
September 4, 2023ASIC's Alex Orgaz-Barnier and DTCC's Priya Kundamal spoke to Regulation Asia about the changes to the derivative transaction reporting regime in Australia.
August 14, 2023The service leverages the UTI to link all Swift messages related to the same securities settlement flow in a transaction chain.
May 19, 2023MAS set October 2024 as the commencement date for its new OTC derivatives reporting rules, aligning with ASIC.
May 17, 2023